Annual EBIT
$1.03 M
+$7.67 M+115.61%
December 31, 2023
Summary
- As of February 12, 2025, HBIO annual earnings before interest & taxes is $1.03 million, with the most recent change of +$7.67 million (+115.61%) on December 31, 2023.
- During the last 3 years, HBIO annual EBIT has risen by +$3.50 million (+142.06%).
- HBIO annual EBIT is now -89.89% below its all-time high of $10.24 million, reached on December 31, 2010.
Performance
HBIO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$3.63 M
-$1.10 M-43.62%
September 30, 2024
Summary
- As of February 12, 2025, HBIO quarterly earnings before interest & taxes is -$3.63 million, with the most recent change of -$1.10 million (-43.62%) on September 30, 2024.
- Over the past year, HBIO quarterly EBIT has dropped by -$3.96 million (-1235.94%).
- HBIO quarterly EBIT is now -149.41% below its all-time high of $7.36 million, reached on March 31, 2000.
Performance
HBIO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$10.21 M
-$3.96 M-63.25%
September 30, 2024
Summary
- As of February 12, 2025, HBIO TTM earnings before interest & taxes is -$10.21 million, with the most recent change of -$3.96 million (-63.25%) on September 30, 2024.
- Over the past year, HBIO TTM EBIT has dropped by -$11.56 million (-855.03%).
- HBIO TTM EBIT is now -146.26% below its all-time high of $22.07 million, reached on September 30, 2000.
Performance
HBIO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
HBIO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +115.6% | -1235.9% | -855.0% |
| 3 y3 years | +142.1% | -969.6% | -2441.3% |
| 5 y5 years | +139.7% | -174.1% | -10000.0% |
HBIO EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -26.1% | +115.6% | -192.3% | +45.2% | -567.4% | at low |
| 5 y | 5-year | -26.1% | +115.6% | -192.3% | +45.2% | -567.4% | at low |
| alltime | all time | -89.9% | +110.0% | -149.4% | +88.8% | -146.3% | +67.7% |
Harvard Bioscience EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.63 M(+43.6%) | -$10.21 M(+63.2%) |
| Jun 2024 | - | -$2.53 M(-32.2%) | -$6.25 M(+28.2%) |
| Mar 2024 | - | -$3.73 M(+1108.1%) | -$4.88 M(-571.4%) |
| Dec 2023 | $1.03 M(-115.6%) | -$309.00 K(-196.6%) | $1.03 M(-23.4%) |
| Sep 2023 | - | $320.00 K(-127.7%) | $1.35 M(-146.5%) |
| Jun 2023 | - | -$1.16 M(-153.0%) | -$2.91 M(-233.2%) |
| Mar 2023 | - | $2.18 M(>+9900.0%) | $2.18 M(-132.9%) |
| Dec 2022 | -$6.63 M(-573.6%) | $8000.00(-100.2%) | -$6.63 M(+29.3%) |
| Sep 2022 | - | -$3.94 M(-200.1%) | -$5.13 M(+566.1%) |
| Jun 2022 | - | $3.94 M(-159.3%) | -$770.00 K(-84.5%) |
| Mar 2022 | - | -$6.63 M(-539.3%) | -$4.96 M(-454.4%) |
| Dec 2021 | $1.40 M(-156.9%) | $1.51 M(+261.2%) | $1.40 M(+221.1%) |
| Sep 2021 | - | $418.00 K(-263.9%) | $436.00 K(-327.1%) |
| Jun 2021 | - | -$255.00 K(-6.6%) | -$192.00 K(-144.9%) |
| Mar 2021 | - | -$273.00 K(-150.0%) | $428.00 K(-117.4%) |
| Dec 2020 | -$2.46 M(+2575.0%) | $546.00 K(-360.0%) | -$2.46 M(+51.2%) |
| Sep 2020 | - | -$210.00 K(-157.5%) | -$1.63 M(-40.7%) |
| Jun 2020 | - | $365.00 K(-111.5%) | -$2.74 M(-4.2%) |
| Mar 2020 | - | -$3.16 M(-329.3%) | -$2.87 M(+3014.1%) |
| Dec 2019 | -$92.00 K(-96.5%) | $1.38 M(-204.0%) | -$92.00 K(-186.8%) |
| Sep 2019 | - | -$1.33 M(-643.4%) | $106.00 K(-94.7%) |
| Jun 2019 | - | $244.00 K(-162.7%) | $1.98 M(+46.4%) |
| Mar 2019 | - | -$389.00 K(-124.7%) | $1.35 M(-151.9%) |
| Dec 2018 | -$2.61 M(+36.7%) | $1.58 M(+186.7%) | -$2.61 M(-41.8%) |
| Sep 2018 | - | $550.00 K(-243.2%) | -$4.48 M(-18.6%) |
| Jun 2018 | - | -$384.00 K(-91.2%) | -$5.50 M(-3.0%) |
| Mar 2018 | - | -$4.35 M(+1379.9%) | -$5.67 M(+197.3%) |
| Dec 2017 | -$1.91 M(-21.8%) | -$294.00 K(-38.1%) | -$1.91 M(-22.0%) |
| Sep 2017 | - | -$475.00 K(-13.9%) | -$2.45 M(-9.7%) |
| Jun 2017 | - | -$552.00 K(-6.0%) | -$2.71 M(-1.3%) |
| Mar 2017 | - | -$587.00 K(-29.5%) | -$2.75 M(+12.6%) |
| Dec 2016 | -$2.44 M(-11.7%) | -$833.00 K(+12.7%) | -$2.44 M(+41.7%) |
| Sep 2016 | - | -$739.00 K(+25.9%) | -$1.72 M(-8.2%) |
| Jun 2016 | - | -$587.00 K(+110.4%) | -$1.87 M(+25.0%) |
| Mar 2016 | - | -$279.00 K(+140.5%) | -$1.50 M(-45.7%) |
| Dec 2015 | -$2.76 M(-151.1%) | -$116.00 K(-87.0%) | -$2.76 M(+123.5%) |
| Sep 2015 | - | -$892.00 K(+320.8%) | -$1.24 M(-245.2%) |
| Jun 2015 | - | -$212.00 K(-86.3%) | $851.00 K(-67.0%) |
| Mar 2015 | - | -$1.54 M(-209.4%) | $2.58 M(-52.3%) |
| Dec 2014 | $5.41 M(+289.0%) | $1.41 M(+18.0%) | $5.41 M(+78.2%) |
| Sep 2014 | - | $1.20 M(-21.3%) | $3.04 M(+39.7%) |
| Jun 2014 | - | $1.52 M(+18.2%) | $2.17 M(+64.9%) |
| Mar 2014 | - | $1.28 M(-233.5%) | $1.32 M(-5.5%) |
| Dec 2013 | $1.39 M(-81.4%) | -$962.00 K(-388.9%) | $1.39 M(-82.0%) |
| Sep 2013 | - | $333.00 K(-49.8%) | $7.73 M(+6.1%) |
| Jun 2013 | - | $663.00 K(-51.2%) | $7.28 M(-7.2%) |
| Mar 2013 | - | $1.36 M(-74.7%) | $7.85 M(+4.9%) |
| Dec 2012 | $7.48 M | $5.37 M(-4982.7%) | $7.48 M(+34.3%) |
| Sep 2012 | - | -$110.00 K(-109.0%) | $5.57 M(-3.6%) |
| Jun 2012 | - | $1.23 M(+23.6%) | $5.78 M(-14.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $991.00 K(-71.4%) | $6.74 M(-11.5%) |
| Dec 2011 | $7.62 M(-25.6%) | $3.46 M(+3431.6%) | $7.62 M(+8.3%) |
| Sep 2011 | - | $98.00 K(-95.5%) | $7.04 M(-19.1%) |
| Jun 2011 | - | $2.19 M(+17.2%) | $8.70 M(-4.8%) |
| Mar 2011 | - | $1.87 M(-35.1%) | $9.13 M(-10.8%) |
| Dec 2010 | $10.24 M(+1.5%) | $2.88 M(+63.7%) | $10.24 M(-21.5%) |
| Sep 2010 | - | $1.76 M(-33.0%) | $13.04 M(+1.7%) |
| Jun 2010 | - | $2.63 M(-11.8%) | $12.82 M(+21.2%) |
| Mar 2010 | - | $2.98 M(-47.6%) | $10.58 M(+4.9%) |
| Dec 2009 | $10.09 M(+25.5%) | $5.68 M(+267.7%) | $10.09 M(+69.0%) |
| Sep 2009 | - | $1.54 M(+305.2%) | $5.97 M(-5.9%) |
| Jun 2009 | - | $381.00 K(-84.7%) | $6.34 M(-24.3%) |
| Mar 2009 | - | $2.49 M(+59.6%) | $8.38 M(+4.2%) |
| Dec 2008 | $8.04 M(-15.7%) | $1.56 M(-18.7%) | $8.04 M(-12.6%) |
| Sep 2008 | - | $1.92 M(-20.7%) | $9.20 M(-0.9%) |
| Jun 2008 | - | $2.42 M(+12.6%) | $9.28 M(-1.5%) |
| Mar 2008 | - | $2.15 M(-20.9%) | $9.42 M(-1.2%) |
| Dec 2007 | $9.53 M(+9.7%) | $2.72 M(+35.8%) | $9.53 M(+4.6%) |
| Sep 2007 | - | $2.00 M(-21.7%) | $9.11 M(+1.5%) |
| Jun 2007 | - | $2.56 M(+13.0%) | $8.98 M(+3.0%) |
| Mar 2007 | - | $2.26 M(-1.5%) | $8.71 M(+0.2%) |
| Dec 2006 | $8.69 M(+9.7%) | $2.30 M(+23.4%) | $8.69 M(-2.3%) |
| Sep 2006 | - | $1.86 M(-18.7%) | $8.90 M(-5.5%) |
| Jun 2006 | - | $2.29 M(+2.2%) | $9.42 M(+9.0%) |
| Mar 2006 | - | $2.24 M(-10.5%) | $8.64 M(+9.1%) |
| Dec 2005 | $7.92 M(-5.5%) | $2.50 M(+5.0%) | $7.92 M(+6.9%) |
| Sep 2005 | - | $2.38 M(+57.4%) | $7.41 M(-0.6%) |
| Jun 2005 | - | $1.51 M(-0.3%) | $7.46 M(+13.9%) |
| Mar 2005 | - | $1.52 M(-23.8%) | $6.55 M(+26.1%) |
| Dec 2004 | $8.38 M(+9.4%) | $2.00 M(-17.9%) | $5.19 M(-10.9%) |
| Sep 2004 | - | $2.43 M(+300.2%) | $5.83 M(+14.5%) |
| Jun 2004 | - | $607.00 K(+272.4%) | $5.09 M(-22.9%) |
| Mar 2004 | - | $163.00 K(-93.8%) | $6.61 M(-13.8%) |
| Dec 2003 | $7.67 M(+92.8%) | $2.63 M(+55.6%) | $7.66 M(+40.3%) |
| Sep 2003 | - | $1.69 M(-20.2%) | $5.46 M(+17.5%) |
| Jun 2003 | - | $2.12 M(+73.5%) | $4.65 M(+15.8%) |
| Mar 2003 | - | $1.22 M(+183.3%) | $4.02 M(+1.0%) |
| Dec 2002 | $3.98 M(+405.6%) | $431.00 K(-51.0%) | $3.98 M(+8.5%) |
| Sep 2002 | - | $880.00 K(-40.7%) | $3.67 M(+30.5%) |
| Jun 2002 | - | $1.49 M(+25.6%) | $2.81 M(+93.7%) |
| Mar 2002 | - | $1.18 M(+898.3%) | $1.45 M(+62.2%) |
| Dec 2001 | $786.40 K(-107.6%) | $118.40 K(+393.3%) | $894.40 K(-102.8%) |
| Sep 2001 | - | $24.00 K(-81.0%) | -$31.62 M(+30.2%) |
| Jun 2001 | - | $126.00 K(-79.9%) | -$24.29 M(+42.4%) |
| Mar 2001 | - | $626.00 K(-101.9%) | -$17.06 M(+65.2%) |
| Dec 2000 | -$10.33 M(-1011.1%) | -$32.40 M(-540.4%) | -$10.33 M(-146.8%) |
| Sep 2000 | - | $7.36 M(0.0%) | $22.07 M(+50.0%) |
| Jun 2000 | - | $7.36 M(0.0%) | $14.71 M(+100.0%) |
| Mar 2000 | - | $7.36 M | $7.36 M |
| Dec 1999 | $1.13 M(-53.0%) | - | - |
| Dec 1998 | $2.41 M | - | - |
FAQ
- What is Harvard Bioscience annual earnings before interest & taxes?
- What is the all time high annual EBIT for Harvard Bioscience?
- What is Harvard Bioscience annual EBIT year-on-year change?
- What is Harvard Bioscience quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Harvard Bioscience?
- What is Harvard Bioscience quarterly EBIT year-on-year change?
- What is Harvard Bioscience TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Harvard Bioscience?
- What is Harvard Bioscience TTM EBIT year-on-year change?
What is Harvard Bioscience annual earnings before interest & taxes?
The current annual EBIT of HBIO is $1.03 M
What is the all time high annual EBIT for Harvard Bioscience?
Harvard Bioscience all-time high annual earnings before interest & taxes is $10.24 M
What is Harvard Bioscience annual EBIT year-on-year change?
Over the past year, HBIO annual earnings before interest & taxes has changed by +$7.67 M (+115.61%)
What is Harvard Bioscience quarterly earnings before interest & taxes?
The current quarterly EBIT of HBIO is -$3.63 M
What is the all time high quarterly EBIT for Harvard Bioscience?
Harvard Bioscience all-time high quarterly earnings before interest & taxes is $7.36 M
What is Harvard Bioscience quarterly EBIT year-on-year change?
Over the past year, HBIO quarterly earnings before interest & taxes has changed by -$3.96 M (-1235.94%)
What is Harvard Bioscience TTM earnings before interest & taxes?
The current TTM EBIT of HBIO is -$10.21 M
What is the all time high TTM EBIT for Harvard Bioscience?
Harvard Bioscience all-time high TTM earnings before interest & taxes is $22.07 M
What is Harvard Bioscience TTM EBIT year-on-year change?
Over the past year, HBIO TTM earnings before interest & taxes has changed by -$11.56 M (-855.03%)